Change of date
Due to unforeseen circumstances, our webinar with Prof Jakub Tolar is now on Thursday 11th December at 2pm.
If you had already registered, your place has been transferred. We apologise for any inconvenience this may cause.
Registration remains open to all.
Prof Jakub Tolar (University of Minnesota) is joining us to talk about his research into immune and cell therapy for recessive dystrophic EB (RDEB) associated squamous cell carcinoma (SCC). You can read more about this research project here.
When? Thursday 11th December, 2pm GMT
Where? Online – register now
Who? This free webinar is open to all – EB patients and families, researchers, clinicians, and anyone with an interest in EB.
Please note that this a live event only – a recording won’t be shared after the event.
Hosted by Sharmila Collins, founder of Cure EB, this is a free event open to all, but you must register.
There will be an opportunity to ask questions, but you can also submit questions in advance here.
Prof Jakub Tolar is the dean of the University of Minnesota Medical School and a Distinguished McKnight University Professor in the Department of Pediatrics, Blood and Marrow Transplant & Cellular Therapy. He is also the vice president for Clinical Affairs at the University of Minnesota, board chair for University of Minnesota Physicians and co-leader of M Health Fairview, the joint clinical enterprise among the University of Minnesota Medical School, University of Minnesota Physicians and Fairview Health Services. An internationally recognized physician and researcher, Dr. Tolar is known for his care of patients with recessive dystrophic epidermolysis bullosa. His research is focused on developing cellular therapies for rare genetic disorders.